A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI (rTMS+iVCT)
Mild Cognitive Impairment, Caregiver Burden, Mental Health Issue
About this trial
This is an interventional treatment trial for Mild Cognitive Impairment focused on measuring repetitive Transcranial Magnetic Stimulation, immersive virtual reality, Neuropsychiatric Symptoms, Mild Cognitive Impairment
Eligibility Criteria
Inclusion Criteria: age 55 and over previous diagnosis of Mild Cognitive Impairment Score of 18 or over on the MoCA during pre-screening procedures. Exclusion Criteria: below 55 years old Do not pass the TMS Adult Safety Screening Taking medications known to increase risk of seizure Taking ototoxic medications Those with implanted device History of bipolar disorder History of Tourette's syndrome or presence of motor tics History of seizures/ seizures in first degree relatives History of stroke, aneurysm, or cranial neurosurgery Current alcohol related disorder needing medical treatment History of abnormal electroencephalogram (EEG) History of motion sickness, nausea, vomiting, seizures, or migraine Significant balance/gait impairments/history of falls History of hyperacusis or photophobia
Sites / Locations
- Central Arkansas VA Healthcare system
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Active Comparator
Experimental
Standard Treatment
rTMS
rTMS+iVCT
This arm will be followed without intervention
This group will be randomized to receive rTMS treatment
This group will be randomized to receive rTMS and iVCT treatment